Caristo Diagnostics Patents

Patent portfolio assigned to Caristo Diagnostics (verified via public assignee records). Estimated patent count: 2. Oxford, UK (founded 2018, University of Oxford spin-out) AI for coronary inflammation / plaque on CCTA (CaRi-Heart, CaRi-Plaque; FDA cleared). At least 2 patents assigned to Caristo Diagnostics Ltd (US10695023B2 perivascular tissue characterisation, US11393137B2 cardiovascular risk prediction). Heart & Lung Health (UK radiologist network) selected and offers the tech as a paying customer; also in NHS/private hospital use. Competitors are other AI-CCTA firms.